The present invention relates to the identification of loss-of-function
mutations in the filaggrin gene and their use in diagnosing ichthyosis
vulgaris and/or susceptibility to other diseases including atopic
dermatitis (eczema), asthma, psoriasis and allergies (including food
allergy).